Igenesis
Company

Last deal

$15.8M
Local Amount - CNY 100M

Amount

Series C

Stage

08.03.2022

Date

5

all rounds

$37.3M

Total amount

General

About Company
Igenesis is a biotechnology company that specializes in molecular diagnostic technologies.

Industry

Sector :

Subsector :

Also Known As

奥然生物, 奥然生物科技(上海)有限公司, Aoran Shengwu

founded date

01.03.2015

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

They develop and manufacture automated PCR analysis systems, fluorescent PCR analysis systems, police forensic products, medical IVD products, and manual nucleic acid extraction kits. Their high-quality diagnostic and sensing equipment is used in medical facilities and other industries. Igenesis's products include fully automated biological detectors, reagents, and reagent smart boxes for applications such as microbial detection, personalized drug-gene detection, cancer detection, forensic evidence, and food safety.